NVS CapEx to Revenue

Novartis AG Common Stock · CapEx to Revenue

NVS logo

NVS CapEx to Revenue

Current (TTM)3.85%
NVS CapEx/Revenue (4.90% → 3.85%)
High-resolution chart · PNG

NVS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
2.8387%
7.374%
5.9001%
6.1457%
6.7563%
5.1806%
4.6367%
7.2778%
6.3266%
5.8237%
7.6428%
6.9042%
7.161%
6.3593%
4.0202%
4.3289%
6.0595%
5.4387%
8.0443%
6.6144%
5.2028%
5.3158%
6.1893%
5.6809%
4.3439%
3.7187%
4.2286%
4.9019%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.